AFMD News and Press, Affimed N.V.

2024-06-29 10:07:31 ET More on Artiva Biotherapeutics, Inc. Financial information for Artiva Biotherapeutics, Inc. Read the full article on Seeking Alpha For further details see: Cell therapy developer Artiva refiles for a $100M IPO

2024-06-17 17:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-12 10:52:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Affimed (NASDAQ: AFMD ) just reported results for the first quarter of 2024. Affimed reported earnings per share of -$1.38. This was above the analyst estimate for EPS of ...

2024-06-12 10:48:05 ET Affimed N.V. (AFMD) Q1 2024 Earnings Conference Call June 12, 2024 08:30 A.M. ET Company Participants Alexander Fudukidis – Head, IR Andreas Harstrick – CMO and Interim CEO Michael Wolf – VP, Finance Conference Ca...

2024-06-12 09:17:41 ET More on Affimed Affimed N.V. 2024 Q1 - Results - Earnings Call Presentation Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better Affimed N.V. (AFMD) Q4 2023 Earnings Call Transcript Affimed gets FDA fast track status for AFM24...

SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...

- Initial data from the LuminICE-203 study shows 85.7% overall response rate (ORR) (6 of 7 patients); 4 out of 7 patients with complete response (CR) - - AFM28 shows single agent efficacy with 2 CR/CRi and 3 stable disease (SD) in 6 patients treated at dose level of 300 mg weekly - ...

2024-06-11 08:37:32 ET Summary Affimed's 06/01/24 update on AFM24 means the company has a second viable commercial asset.  This is why the stock popped after ASCO. Acimtamig's update is due before the end of this month.  If it is positive, the stock should run again for ...

2024-06-09 08:01:00 ET More on companies reporting earnings during the week FuelCell Energy: Consider Potential Q2 Results Miss And Korean Market Opportunities Oracle: Strong EPS Growth Expected In 2025 And 2026, Watching Q4 Margins (Rating Upgrade) Broadcom: It's To...

2024-06-08 03:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...